| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |